Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2025-12-23 00:00:00 ET · period of report 2025-12-19 · accession 0001194712-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-23 | 2025-12-19 | CAPR | DUNBAR GEORGE W JR | Dir | M - OptEx | $1.39 | +3,000 | 14.3K | +27% | +$4,170 |
| D | 2025-12-23 | 2025-12-19 | CAPR | DUNBAR GEORGE W JR | Dir | M - OptEx | $0.00 | -3,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-19 | M | A | 3,000 | $1.39 | 14,306 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-12-19 | M | D | 3,000 | $0.00 | 0 | D | $1.39 · — to 2025-03-03 | 3,000 Common Stock | (F1) This option was granted on June 2, 2016 and was previously reported as covering 30,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020. (F2) The shares were fully vested and exercisable as of December 31, 2016. |